Camillo Ricordi holds the M.D. degree and is the Stacy Joy Goodman Professor of surgery, Distinguished Professor of medicine, Professor of biomedical engineering, and microbiology and immunology, and Scientific Director and Chief Academic Officer of the University of Miami Diabetes Research Institute, Fla, USA. He also serves as the Chief of the Division of Cellular Transplantation, Department of Surgery and is an Adjunct Professor at the Wake Forest Institute for Regenerative Medicine, Wake Forest University, Nc, USA and at the Karolinska Institutet in Stockholm, Sweden. He also serves as the President of Mediterranean Institute of Transplantation and Advanced Therapies (ISMETT) in Palermo, Sicily and on the Board of the DRI at H. San Raffaele Institute in Milan, Italy. His research objective is to develop a cure for Type 1 Diabetes, and he is known for pioneering islet isolation techniques that are now used worldwide and for performing the first successful series of human islet allografts. Dr. Ricordi’s research interests include induction of immune tolerance, cellular therapies, stem cells, and regenerative medicine strategies. Founder and President of the CTS and IPITA, he currently is a Councilor of The Transplantation Society, after serving on the council of the ASTS. He has been serving on several NIH Expert Panels, Strategic Planning Committees, on the NCRR Islet Cell Resources Executive Committee, and as the Chairperson of the NIH Clinical Islet Transplant Consortium. Honors and awards include 2001 World Prize of Surgery (Geneva), 2002 Outstanding Scientific Achievement Award (ADA), 2006 Rotary International Paul Harris Fellowship Award, and 2008 NIAF Special Achievement Award, as well as delivery of the Galileo Lecture at EASD Congress in Rome. Dr. Ricordi has authored over 500 scientific publications and has been awarded 9 patents.
Biography Updated on 16 January 2011